Skip to content
Triangle logo TriangleGet started
← Full study record

NCT05061095 · OUTCOME

Acceptability of Best-Worst Scaling (BWS) Survey to Patients

Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey · Source last updated 2024-12-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to 7 days after treatment decision

What was measured

Number of patients who respond with agree/strongly agree to "I found survey acceptable to clarify my preferences"

Analysis population: Participants with newly-diagnosed hematologic malignancies who completed Best-Worst Scaling (BWS) survey.

Groups in this outcome

Pilot Testing: Participants With Newly-diagnosed Hematologic Malignancies

Participants diagnosed participating in the questionnaire portion of the study.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Pilot Testing: Participants With Newly-diagnosed Hematologic Malignancies19

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pilot Testing: Participants With Newly-diagnosed Hematologic Malignancies13Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        13
denoms
  1. counts
    1. group Id
      OG000
      value
      19
    units
    Participants
description
Number of patients who respond with agree/strongly agree to "I found survey acceptable to clarify my preferences"
groups
  1. description
    Participants diagnosed participating in the questionnaire portion of the study.
    id
    OG000
    title
    Pilot Testing: Participants With Newly-diagnosed Hematologic Malignancies
param Type
COUNT_OF_PARTICIPANTS
population Description
Participants with newly-diagnosed hematologic malignancies who completed Best-Worst Scaling (BWS) survey.
reporting Status
POSTED
time Frame
Up to 7 days after treatment decision
title
Acceptability of Best-Worst Scaling (BWS) Survey to Patients
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice